Source:http://linkedlifedata.com/resource/pubmed/id/11914486
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 4
|
pubmed:dateCreated |
2002-3-26
|
pubmed:databankReference | |
pubmed:abstractText |
The crystal structure of the complex of human recombinant aldose reductase (AR) with zenarestat, one of its potent inhibitors, has been solved at 2.5 A resolution. Zenarestat fits neatly in the hydrophobic active site and induces unique and dramatic conformational changes. For example, the benzene ring of zenarestat occupies a gap in the side chains of Leu300 and Trp111 that interact directly and forms a CH-pi interaction in the native holoenzyme. As a result, the benzene ring of the inhibitor and these side chains form a CH-pi-pi interaction. Such structural information is key to understanding the mode of action of this class of inhibitors and for rational design of better therapeutics.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldehyde Reductase,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/FR 74366,
http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0907-4449
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
622-6
|
pubmed:dateRevised |
2007-7-24
|
pubmed:meshHeading |
pubmed-meshheading:11914486-Aldehyde Reductase,
pubmed-meshheading:11914486-Crystallography, X-Ray,
pubmed-meshheading:11914486-Enzyme Inhibitors,
pubmed-meshheading:11914486-Humans,
pubmed-meshheading:11914486-Models, Molecular,
pubmed-meshheading:11914486-Quinazolines,
pubmed-meshheading:11914486-Recombinant Proteins
|
pubmed:year |
2002
|
pubmed:articleTitle |
The structure of human recombinant aldose reductase complexed with the potent inhibitor zenarestat.
|
pubmed:affiliation |
Exploratory Research Laboratories, Fujisawa Pharmaceutical Co. Ltd, 5-2-3, Tokodai, Tsukuba, Ibaraki 300-2698, Japan. takayoshi_kinoshita@po.fujisawa.co.jp
|
pubmed:publicationType |
Journal Article
|